Stay updated on Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study record describes a completed phase II melanoma trial of pembrolizumab, ipilimumab, and aspirin, including its eligibility criteria, treatment plan, outcomes, and results.
    Difference
    58%
    Check dated 2026-11-07T11:10:43.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T10:08:37.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content. The study page itself continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-24T10:08:38.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T12:32:46.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T13:43:13.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site chrome (header, navigation, and footer), replacing the previous study content. This indicates restricted access rather than a substantive update to study data.
    Difference
    20%
    Check dated 2026-09-19T18:40:12.000Z thumbnail image

Stay in the know with updates to Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prostaglandin Inhibition & Checkpoint Blockade in Melanoma Clinical Trial page.